Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Wegovy“
Suchtreffer
Begriffe & Kennungen
Wegovy · 4.8 Undesirable effects · 2
Eintrag öffnenWegovy · 4.8 · 10 MedDRA Very Uncommo system Common Rare Very Not known common n organ class rare Gastrointestin Vomitinga,b
Eintrag öffnenWegovy · 4.8 · 12 Dysaesthesia Events related to a clinical picture of altered skin sensation such as paraesthesia, pain of s
Eintrag öffnenWegovy · 4.8 · 46 MedDRA Very Uncommo Very system Common Rare Not known common n rare organ class Vascular Hypotensio disorde
Eintrag öffnenWegovy · 4.8 · 47 Acute pancreatitis Acute pancreatitis was reported in 0 % of patients treated with oral semaglutide and 1.0
Eintrag öffnenWegovy · 4.8 · 48 oral semaglutide. No events were reported in patients treated with placebo. The events were mild to moderat
Eintrag öffnenWegovy · 4.8 · Acute gallstone disease/Cholelithiasis Cholelithiasis was reported in 1.6% and led to cholecystitis in 0.6% of
Eintrag öffnenWegovy · 4.8 · Acute gallstone disease/Cholelithiasis Cholelithiasis was reported in 2.5 % and led to cholecystitis in 0 % of
Eintrag öffnenWegovy · 4.8 · Acute pancreatitis The frequency of adjudication-confirmed acute pancreatitis reported in phase 3a clinical tr
Eintrag öffnenWegovy · 4.8 · Adverse reactions are listed by MedDRA system organ class and frequency. Frequency categories are defined as:
Eintrag öffnenWegovy · 4.8 · Adverse reactions are listed by MedDRA system organ class and frequency. Frequency categories are defined as:
Eintrag öffnenWegovy · 4.8 · Description of selected adverse reactions
Eintrag öffnenWegovy · 4.8 · Description of selected adverse reactions
Eintrag öffnenWegovy · 4.8 · Diabetic retinopathy in patients with type 2 diabetes A 2-year clinical trial investigated semaglutide 0.5 mg
Eintrag öffnenWegovy · 4.8 · Diabetic retinopathy in patients with type 2 diabetes A 2-year clinical trial investigated subcutaneous semagl
Eintrag öffnenWegovy · 4.8 · Dysaesthesia Events related to a clinical picture of altered skin sensation such as sensitive skin, hyperaesth
Eintrag öffnenWegovy · 4.8 · Gastrointestinal adverse reactions Over the 68 weeks trial period, nausea occurred in 43.9% of patients when t
Eintrag öffnenWegovy · 4.8 · Gastrointestinal adverse reactions The events were most frequently reported during dose escalation. Over the 6
Eintrag öffnenWegovy · 4.8 · Hair loss Hair loss was reported in 2.5% of patients treated with semaglutide and in 1.0% of patients treated
Eintrag öffnenWegovy · 4.8 · Hair loss Hair loss was reported in 6.4 % of patients treated with oral semaglutide and in 2.0 % of patients t
Eintrag öffnen